These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2447091)

  • 21. Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity.
    Webb DJ; Hussaini IM; Weaver AM; Atkins TL; Chu CT; Pizzo SV; Owens GK; Gonias SL
    Eur J Biochem; 1995 Dec; 234(3):714-22. PubMed ID: 8575427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
    Gonias SL; Balber AE; Hubbard WJ; Pizzo SV
    Biochem J; 1983 Jan; 209(1):99-105. PubMed ID: 6189480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes.
    Borth W; Urbanski A; Prohaska R; Susanj M; Luger TA
    Blood; 1990 Jun; 75(12):2388-95. PubMed ID: 1693530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.
    Wakefield LM; Smith DM; Flanders KC; Sporn MB
    J Biol Chem; 1988 Jun; 263(16):7646-54. PubMed ID: 3163692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.
    Webb DJ; Weaver AM; Atkins-Brady TL; Gonias SL
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):551-5. PubMed ID: 8973565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes.
    Lonberg-Holm K; Reed DL; Roberts RC; Hebert RR; Hillman MC; Kutney RM
    J Biol Chem; 1987 Jan; 262(1):438-45. PubMed ID: 2432067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding.
    Chu CT; Rubenstein DS; Enghild JJ; Pizzo SV
    Biochemistry; 1991 Feb; 30(6):1551-60. PubMed ID: 1704257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha 2-macroglobulin is mediated via an alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism.
    Bonner JC; Badgett A; Hoffman M; Lindroos PM
    J Biol Chem; 1995 Mar; 270(11):6389-95. PubMed ID: 7534312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.
    Coté N; Trout DR; Hayes AM
    Can J Vet Res; 1996 Apr; 60(2):150-7. PubMed ID: 8785722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines.
    Feige JJ; Negoescu A; Keramidas M; Souchelnitskiy S; Chambaz EM
    Horm Res; 1996; 45(3-5):227-32. PubMed ID: 8964589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
    Soker S; Svahn CM; Neufeld G
    J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha 2-macroglobulin binds and inhibits activated protein C.
    Hoogendoorn H; Toh CH; Nesheim ME; Giles AR
    Blood; 1991 Nov; 78(9):2283-90. PubMed ID: 1718493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
    McCaffrey TA; Falcone DJ; Brayton CF; Agarwal LA; Welt FG; Weksler BB
    J Cell Biol; 1989 Jul; 109(1):441-8. PubMed ID: 2473082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the binding of chicken alpha-macroglobulin and ovomacroglobulin to the mammalian alpha 2-macroglobulin receptor.
    Feldman SR; Pizzo SV
    Arch Biochem Biophys; 1984 Nov; 235(1):267-75. PubMed ID: 6208849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor binding to human alpha 2-macroglobulin. Implications for alpha 2-macroglobulin-growth factor interactions.
    Gettins PG; Crews BC
    Biochemistry; 1993 Aug; 32(31):7916-21. PubMed ID: 7688570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.
    Barrett AJ; Brown MA; Sayers CA
    Biochem J; 1979 Aug; 181(2):401-18. PubMed ID: 91367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts.
    Lindroos PM; Coin PG; Osornio-Vargas AR; Bonner JC
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):455-65. PubMed ID: 7546776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of a "half-molecule" alpha 2-macroglobulin from the southern grass frog: absence of binding to the mammalian alpha 2-macroglobulin receptor.
    Feldman SR; Pizzo SV
    Biochemistry; 1986 Feb; 25(3):721-7. PubMed ID: 2420357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions.
    Crookston KP; Webb DJ; Wolf BB; Gonias SL
    J Biol Chem; 1994 Jan; 269(2):1533-40. PubMed ID: 7507109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy.
    Lauer D; Müller R; Cott C; Otto A; Naumann M; Birkenmeier G
    Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S4-9. PubMed ID: 11561872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.